Works matching IS 00070920 AND DT 2024 AND VI 130 AND IP 3

Results: 18

CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 467, doi. 10.1038/s41416-023-02542-1

By:

Javed, S. R.;
Lord, S.;
El Badri, S.;
Harman, R.;
Holmes, J.;
Kamzi, F.;
Maughan, T.;
McIntosh, D.;
Mukherjee, S.;
Ooms, A.;
Radhakrishna, G.;
Shaw, P.;
Hawkins, M. A.

Publication type:

Article

Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 406, doi. 10.1038/s41416-023-02537-y

By:

Hsieh, Hsin-Hua;
Chen, Chuan-Lin;
Chan, Hui-Wen;
Chi, Kwan-Hwa;
Wu, Chun-Yi

Publication type:

Article

NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 476, doi. 10.1038/s41416-023-02534-1

By:

Cecchini, Michael;
Cleary, James M.;
Shyr, Yu;
Chao, Joseph;
Uboha, Nataliya;
Cho, May;
Shields, Anthony;
Pant, Shubham;
Goff, Laura;
Spencer, Kristen;
Kim, Edward;
Stein, Stacey;
Kortmansky, Jeremy S.;
Canosa, Sandra;
Sklar, Jeffrey;
Swisher, Elizabeth M.;
Radke, Marc;
Ivy, Percy;
Boerner, Scott;
Durecki, Diane E.

Publication type:

Article

Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 504, doi. 10.1038/s41416-023-02533-2

By:

Pang, Yuanjie;
Lv, Jun;
Wu, Ting;
Yu, Canqing;
Guo, Yu;
Chen, Yiping;
Yang, Ling;
Millwood, Iona Y.;
Walters, Robin G.;
Yang, Xiaoming;
Stevens, Rebecca;
Clarke, Robert;
Chen, Junshi;
Li, Liming;
Chen, Zhengming;
Kartsonaki, Christiana

Publication type:

Article

A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 450, doi. 10.1038/s41416-023-02519-0

By:

Chen, Bolin;
Yao, Wenxiu;
Li, Xingya;
Lin, Gen;
Chu, Qian;
Liu, Hailong;
Du, Yingying;
Lin, Jie;
Duan, Huaxin;
Wang, Huijuan;
Xiao, Zemin;
Sun, Hong;
Liu, Liyu;
Xu, Li;
Xu, Yan;
Xu, Fang;
Kong, Yi;
Pu, Xingxiang;
Li, Kang;
Wang, Qianzhi

Publication type:

Article

Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 425, doi. 10.1038/s41416-023-02528-z

By:

Zebic, Danka Sinikovic;
Tjokrowidjaja, Angelina;
Francis, Katherine Elizabeth;
Friedlander, Michael;
Gebski, Val;
Lortholary, Alain;
Joly, Florence;
Hasenburg, Annette;
Mirza, Mansoor;
Denison, Ursula;
Cecere, Sabrina Chiara;
Ferrero, Annamaria;
Pujade-Lauraine, Eric;
Lee, Chee Khoon

Publication type:

Article

Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3

By:

Flecchia, Clémence;
Auclin, Edouard;
Alouani, Emily;
Mercier, Mathilde;
Hollebecque, Antoine;
Turpin, Anthony;
Mazard, Thibault;
Pernot, Simon;
Dutherage, Marie;
Cohen, Romain;
Borg, Christophe;
Hautefeuille, Vincent;
Sclafani, Francesco;
Ben-Abdelghani, Meher;
Aparicio, Thomas;
De La Fouchardière, Christelle;
Herve, Camille;
Perkins, Geraldine;
Heinrich, Kathrin;
Kunzmann, Volker

Publication type:

Article

PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 394, doi. 10.1038/s41416-023-02523-4

By:

Lyu, Liang;
Li, Haiyan;
Lu, Kefeng;
Jiang, Shu;
Li, Huihui

Publication type:

Article

Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.

Published in:

2024

By:

Stögbauer, Fabian;
Beck, Susanne;
Ourailidis, Iordanis;
Hess, Jochen;
Poremba, Christopher;
Lauterbach, Maren;
Wollenberg, Barbara;
Buchberger, Anna Maria Stefanie;
Jesinghaus, Moritz;
Schirmacher, Peter;
Stenzinger, Albrecht;
Weichert, Wilko;
Boxberg, Melanie;
Budczies, Jan

Publication type:

Correction Notice

Association between weight cycling and risk of colorectal cancer: a prospective cohort study.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 496, doi. 10.1038/s41416-023-02529-y

By:

Kim, Suryun;
Lee, Dong Hoon;
Giovannucci, Edward L.;
Keum, NaNa

Publication type:

Article

Factors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 483, doi. 10.1038/s41416-023-02518-1

By:

Mavor, Meaghan E.;
Hanna, Timothy P.;
Asai, Yuka;
Langley, Hugh;
Look Hong, Nicole J.;
Wright, Frances C.;
Nguyen, Paul;
Groome, Patti A.

Publication type:

Article

Periostin–TGF-β feedforward loop contributes to tumour-stroma crosstalk in liver metastatic outgrowth of colorectal cancer.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 358, doi. 10.1038/s41416-023-02516-3

By:

Liu, Bin;
Wu, Tiantian;
Lin, Biyu;
Liu, Xingxing;
Liu, Yingfu;
Song, Gang;
Fan, Chuannan;
Ouyang, Gaoliang

Publication type:

Article

Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 457, doi. 10.1038/s41416-023-02515-4

By:

Grosser, Bianca;
Emmerson, Jake;
Reitsam, Nic G.;
Cunningham, David;
Nankivell, Matthew;
Langley, Ruth E.;
Allum, William H.;
Trepel, Martin;
Märkl, Bruno;
Grabsch, Heike I.

Publication type:

Article

Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 417, doi. 10.1038/s41416-023-02514-5

By:

Postel-Vinay, Sophie;
Coves, Juan;
Texier, Matthieu;
Aldea, Mihaela;
Gazzah, Anas;
Dómine, Manuel;
Planchard, David;
De Las Peñas, Ramon;
Sala Gonzalez, Ma Angeles;
Viteri, Santiago;
Perez, Javier;
Ortega, Ana Laura;
Moran, Teresa;
Camps, Carlos;
Lopez-Martin, Ana;
Provencio, Mariano;
Soria, Jean-Charles;
Besse, Benjamin;
Massuti, Bartomeu;
Rosell, Rafael

Publication type:

Article

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 434, doi. 10.1038/s41416-023-02513-6

By:

Font, Albert;
Mellado, Begona;
Climent, Miguel A.;
Virizuela, Juan Antonio;
Oudard, Stephane;
Puente, Javier;
Castellano, Daniel;
González-del-Alba, Aranzazu;
Pinto, Alvaro;
Morales-Barrera, Rafael;
Rodriguez-Vida, Alejo;
Fernandez, Pedro L.;
Teixido, Cristina;
Jares, Pedro;
Aldecoa, Iban;
Gibson, Neil;
Solca, Flavio;
Mondal, Shoubhik;
Lorence, Robert M.;
Serra, Josep

Publication type:

Article

MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 380, doi. 10.1038/s41416-023-02495-5

By:

Liang, Qiaoyan;
Hu, Yajun;
Yuan, Qingyun;
Yu, Min;
Wang, Huijie;
Zhao, Bing

Publication type:

Article

Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 369, doi. 10.1038/s41416-023-02494-6

By:

Viergever, Bastiaan J.;
Raats, Daniëlle A. E.;
Geurts, Veerle;
Mullenders, Jasper;
Jonges, Trudy N.;
van der Heijden, Michiel S.;
van Es, Johan H.;
Kranenburg, Onno;
Meijer, Richard P.

Publication type:

Article

Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.

Published in:

British Journal of Cancer, 2024, v. 130, n. 3, p. 347, doi. 10.1038/s41416-023-02485-7

By:

O'Malley, Dannielle E.;
Raspin, Kelsie;
Melton, Phillip E.;
Burdon, Kathryn P.;
Dickinson, Joanne L.;
FitzGerald, Liesel M.

Publication type:

Article